佛慈制药
(002644)
| 流通市值：43.41亿 | | | 总市值：43.41亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 440,320,280.34 | 211,574,701.05 | 915,533,598.79 | 624,055,200.7 |
| 营业总成本 | 394,915,425.87 | 183,095,248.39 | 813,851,221.73 | 564,312,051.85 |
| 其他经营收益 | | | | |
| 营业利润 | 45,697,247.22 | 27,124,980.34 | 65,985,504.49 | 43,583,039.52 |
| 利润总额 | 44,416,206.06 | 27,032,897.22 | 65,030,429.01 | 42,275,880.22 |
| 净利润 | 37,955,735.58 | 22,871,613.71 | 46,955,016.44 | 37,144,761.73 |
| 每股收益 | | | | |
| 其他综合收益 | -156,937.64 | - | -90,160.47 | 43,576.26 |
| 综合收益总额 | 37,798,797.94 | 22,871,613.71 | 46,864,855.97 | 37,188,337.99 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,422,063,804.33 | 1,363,162,459.43 | 1,332,741,137.11 | 1,322,828,440.81 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,198,090,300.65 | 1,200,293,721.98 | 1,214,755,339.92 | 1,201,129,467.98 |
| 资产总计 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 |
| 流动负债: | | | | |
| 流动负债合计 | 493,537,485.05 | 447,842,745.85 | 440,621,459.18 | 426,174,040.99 |
| 非流动负债: | | | | |
| 非流动负债合计 | 243,601,077.37 | 247,030,319.21 | 251,410,753.04 | 251,838,731.89 |
| 负债合计 | 737,138,562.42 | 694,873,065.06 | 692,032,212.22 | 678,012,772.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,862,079,336.11 | 1,845,324,107.5 | 1,832,669,317.64 | 1,821,865,251.12 |
| 股东权益合计 | 1,883,015,542.56 | 1,868,583,116.35 | 1,855,464,264.81 | 1,845,945,135.91 |
| 负债和股东权益合计 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 538,829,847.95 | 233,494,128.1 | 943,398,933.27 | 615,352,024.64 |
| 经营活动现金流出小计 | 378,470,479.19 | 177,506,557.23 | 759,449,585.8 | 521,846,802.75 |
| 经营活动产生的现金流量净额 | 160,359,368.76 | 55,987,570.87 | 183,949,347.47 | 93,505,221.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 392,671.23 | - | 270,312.73 | - |
| 投资活动现金流出小计 | 25,677,935.83 | 1,798,162.19 | 38,567,318.98 | 17,798,690.52 |
| 投资活动产生的现金流量净额 | -25,285,264.6 | -1,798,162.19 | -38,297,006.25 | -17,798,690.52 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,000,000 | 0 | 16,000,000 | 14,000,000 |
| 筹资活动现金流出小计 | 26,952,261.34 | 13,439,233.33 | 31,852,925.38 | 37,933,988.62 |
| 筹资活动产生的现金流量净额 | -24,952,261.34 | -13,439,233.33 | -15,852,925.38 | -23,933,988.62 |
| 汇率变动对现金及现金等价物的影响 | - | - | -188,980.2 | - |
| 现金及现金等价物净增加额 | 110,121,842.82 | 40,750,175.35 | 129,610,435.64 | 51,772,542.75 |
| 期末现金及现金等价物余额 | 634,614,408.79 | 565,242,741.32 | 524,492,555.97 | 448,669,550.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 110,121,842.82 | - | 129,610,435.64 | - |